RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
52 hedge funds and large institutions have $125M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
14% less capital invested
Capital invested by funds: $146M → $125M (-$20.4M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.18M | |
| 2 | +$1.97M | |
| 3 | +$1.88M | |
| 4 |
Millennium Management
New York
|
+$951K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$754K |
Top Sellers
| 1 | -$6.77M | |
| 2 | -$225K | |
| 3 | -$128K | |
| 4 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$87.4K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$42.3K |